focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.40
Bid: 51.70
Ask: 52.00
Change: -1.30 (-2.47%)
Spread: 0.30 (0.58%)
Open: 55.00
High: 55.00
Low: 51.40
Prev. Close: 52.70
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further re Scrip Dividend

29 Jun 2022 09:16

RNS Number : 6180Q
IP Group PLC
29 June 2022
 

FOR RELEASE ON

29 June 2022

 

IP Group plc - Further re Scrip Dividend

 

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which develops world-changing science and technology businesses across life sciences, technology and cleantech, announces that further to the announcement made on 06 June 2022 in relation to the Scrip Dividend, the Group has received valid elections from certain shareholders. IP Group intends to sell Ordinary Shares which are currently held in treasury to satisfy such elections and will transfer these shares pursuant to the Scrip Dividend Terms and Conditions ("the Scrip Dividend Shares"). 

 

330,851 Scrip Dividend Shares will be transferred to relevant shareholders on 30 June 2022. Following such transfer, and in accordance with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Group will have 1,063,033,287 Ordinary Shares in issue and 28,607,622 shares in Treasury.

 

The total number of Ordinary Shares with voting rights following the satisfaction of the transfer will be 1,034,425,665 Ordinary Shares. This figure may be used by shareholders in the Group as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Group under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

David Baynes, Chief Financial and Operating OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7967 312125

 

Notes for editors

 

About IP Group

 

IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURMZGZVRLMGZZG
Date   Source Headline
16th Nov 20215:46 pmRNSTransaction in Own Shares
15th Nov 20215:34 pmRNSTransaction in Own Shares
15th Nov 20217:00 amRNSTransaction in Own Shares
11th Nov 20216:11 pmRNSTransaction in Own Shares
11th Nov 20217:09 amRNSPortfolio company RFC Power signs JDA with Ceres
10th Nov 20216:22 pmRNSTransaction in Own Shares
9th Nov 20216:12 pmRNSTransaction in Own Shares
8th Nov 20216:11 pmRNSTransaction in Own Shares
5th Nov 20215:24 pmRNSTransaction in Own Shares
4th Nov 20216:08 pmRNSTransaction in Own Shares
3rd Nov 20216:27 pmRNSTransaction in Own Shares
2nd Nov 20216:15 pmRNSTransaction in Own Shares
1st Nov 20216:12 pmRNSTransaction in Own Shares
29th Oct 20215:35 pmRNSTransaction in Own Shares
29th Oct 20212:02 pmRNSPortfolio co Hinge Health completes $400m round
28th Oct 20216:21 pmRNSTransaction in Own Shares
27th Oct 20215:43 pmRNSDirector/PDMR Shareholding
27th Oct 20215:25 pmRNSTransaction in Own Shares
26th Oct 20215:56 pmRNSTransaction in Own Shares
25th Oct 20216:28 pmRNSTransaction in Own Shares
25th Oct 20217:00 amRNSAdditional fair value gain of £27.5m
22nd Oct 20216:29 pmRNSTransaction in Own Shares
21st Oct 20216:00 pmRNSTransaction in Own Shares
20th Oct 20215:56 pmRNSTransaction in Own Shares
19th Oct 20216:31 pmRNSTransaction in Own Shares
19th Oct 20217:00 amRNSTransaction in Own Shares
18th Oct 20217:00 amRNSTransaction in Own Shares
14th Oct 20216:27 pmRNSTransaction in Own Shares
13th Oct 20216:22 pmRNSTransaction in Own Shares
13th Oct 202111:36 amRNSDirector Declaration
13th Oct 20219:03 amRNSHolding(s) in Company
12th Oct 20216:20 pmRNSTransaction in Own Shares
12th Oct 20212:09 pmRNSDirector/PDMR Shareholding
12th Oct 20217:00 amRNSTransaction in Own Shares
11th Oct 20217:41 amRNSTransaction in Own Shares
8th Oct 20217:00 amRNSShare buyback programme
6th Oct 20217:00 amRNSBoard changes
5th Oct 20214:44 pmRNSHolding(s) in Company
30th Sep 20214:11 pmRNSTotal Voting Rights
30th Sep 20217:45 amRNSIP Group generates £84m from Oxford Nanopore IPO
27th Sep 202112:40 pmRNSDirector/PDMR Shareholding
23rd Sep 20213:57 pmRNSFurther re Scrip Dividend
16th Sep 20217:08 amRNSOxford Nanopore confirms ITF; MoU with Oracle
10th Sep 20215:21 pmRNSHolding(s) in Company
8th Sep 202110:53 amRNSDirector/PDMR Shareholding, SAYE scheme
19th Aug 202110:41 amRNSScrip Dividend Reference Price
12th Aug 20215:05 pmRNSDirector Declaration
5th Aug 20217:00 amRNSHalf-yearly results
27th Jul 20217:03 amRNSPortfolio company Artios Pharma raises $153m
22nd Jul 202111:30 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.